Gossamer Bio (NASDAQ:GOSS) Given “Buy” Rating at HC Wainwright
The Cerbat Gem -

HC Wainwright reiterated their buy rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a research report sent to investors on Monday, Benzinga reports. HC Wainwright currently has a $10.00 price target on the stock. A number of other analysts also recently issued reports on GOSS. The Goldman Sachs Group reduced their price […]

In related news